Drug Approval | December 12, 2023
Merck Animal Health receives positive CVMP opinion for an injectable formulation of Bravecto
The CVMP recommends the product for approval for the treatment and persistent killing of fleas
The CVMP recommends the product for approval for the treatment and persistent killing of fleas
Conditional marketing authorization is based on clinically meaningful response rates, duration of response, and safety from the Phase 2 MagnetisMM-3 trial
Multi-ethnic innovation helps all complexions appear clearer and more uniform
Establishes connected software and data foundation for the future with next-generation life sciences CRM and harmonized customer data
Decision on EU marketing authorisation expected for momelotinib by early 2024
Nerivio is a prescription-based non-invasive device intended for acute and prophylactic (preventive) treatment of migrain
Yesafili, received marketing authorization approval from the European Commission for the European Union
he company posted total income during Q2 FY24 at Rs. 12.86 crore
We are redesigning Bayer to focus only on what’s essential for our mission, ‘Health for all, hunger for none’”
Lack of technology transfer stands out as a formidable barrier
Subscribe To Our Newsletter & Stay Updated
